SeekingAlpha · Aug 17, 2026
Solana Company 2026 Q2 - Results - Earnings Call Presentation
2026-08-17. The following slide deck was published by Solana Company in conjunction with their 2026 Q2 earnings call.
NASDAQ · HSDT
Healthcare · Medical - Devices
$2.10
Up+$0.24 (+12.90%)
Updated Aug 22, 2026, 12:41 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
HSDT closed at $2.10 after 21 trading sessions, up 28.83% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $1.93 | $2.11 | $1.89 | $2.10 | 783.84K |
| Aug 20, 2026 | $1.89 | $1.91 | $1.805 | $1.86 | 304.75K |
| Aug 19, 2026 | $1.78 | $1.88 | $1.7703 | $1.86 | 228.02K |
| Aug 18, 2026 | $1.64 | $1.79 | $1.62 | $1.78 | 185.7K |
| Aug 17, 2026 | $1.70 | $1.7163 | $1.65 | $1.66 | 122.28K |
| Aug 14, 2026 | $1.81 | $1.81 | $1.69 | $1.70 | 137.48K |
| Aug 13, 2026 | $1.74 | $1.8101 | $1.735 | $1.80 | 139.63K |
| Aug 12, 2026 | $1.75 | $1.7649 | $1.73 | $1.74 | 85.2K |
| Aug 11, 2026 | $1.70 | $1.765 | $1.695 | $1.74 | 61.95K |
| Aug 10, 2026 | $1.73 | $1.76 | $1.69 | $1.70 | 149.8K |
| Aug 7, 2026 | $1.69 | $1.7255 | $1.68 | $1.69 | 64.31K |
| Aug 6, 2026 | $1.72 | $1.765 | $1.66 | $1.68 | 35.87K |
| Aug 5, 2026 | $1.64 | $1.74 | $1.635 | $1.72 | 146.63K |
| Aug 4, 2026 | $1.63 | $1.698 | $1.63 | $1.66 | 143.93K |
| Aug 3, 2026 | $1.65 | $1.69 | $1.63 | $1.68 | 92.5K |
| Jul 31, 2026 | $1.69 | $1.70 | $1.64 | $1.65 | 29.22K |
| Jul 30, 2026 | $1.67 | $1.725 | $1.67 | $1.70 | 100.01K |
| Jul 29, 2026 | $1.69 | $1.71 | $1.63 | $1.65 | 62.07K |
| Jul 28, 2026 | $1.67 | $1.71 | $1.61 | $1.69 | 128.02K |
| Jul 27, 2026 | $1.70 | $1.73 | $1.6401 | $1.68 | 183.07K |
| Jul 24, 2026 | $1.68 | $1.69 | $1.62 | $1.63 | 124.92K |
The latest Smart Investors Daily articles mentioning HSDT.
HSDT research
Company profile and research snapshot.
Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities. Through this model, Solana Company provides public market investors with efficient and direct exposure to Solana's long-term growth potential.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 17, 2026 | B. Riley Securities | Buy | — |
| Oct 16, 2024 | Maxim Group | Hold | — |
| Mar 5, 2024 | Roth MKM | Buy | — |
| Dec 20, 2022 | Maxim Group | Buy | — |
| Aug 23, 2022 | Roth Capital | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Aug 17, 2026
2026-08-17. The following slide deck was published by Solana Company in conjunction with their 2026 Q2 earnings call.
Benzinga · Aug 17, 2026
B. Riley Securities analyst Fedor Shabalin maintains Solana (NASDAQ:HSDT) with a Buy and lowers the price target from $3 to $2.5.
SeekingAlpha · Aug 14, 2026
Solana Company (HSDT) Q2 2026 Earnings Call August 14, 2026 4:30 PM EDTCompany ParticipantsJake MorakisChoon Wee Chee - CEO, President & ChairmanCosmo...
Benzinga · Aug 14, 2026
On Friday, Helius Medical Tech (NASDAQ:HSDT) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning HSDT.